offener Laptop auf Schreibtisch

Neuigkeiten

Aktuelles aus dem GMP-Umfeld und von der Valicare GmbH

Nachrichten aus aller Welt

Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).

Cell & Gene Therapies: FDA Regulatory Implications For 2024

20.04.2024 | Pharma Advancement

The fact is that most in the biotech industry know that cell and gene therapies- CGT are regulated across the U.S. as biological products ...

CGTLive®’s Weekly Rewind – April 19, 2024

19.04.2024 | CGTLive

Review top news and interview highlights from the week ending April 19, 2024.

Gene therapy is halting cancer. Can it work against brain tumors?

19.04.2024 | EurekAlert!

University of California - San Francisco Grant of up to $11 million will fund a clinical trial at UCSF that uses a smarter new CAR-T ...

Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma

19.04.2024 | Oncology - CancerNetwork

Omid Hamid, MD, gives his perspective on the use of tumor-infiltrating lymphocyte therapy for patients with melanoma.

FDA Calls for Boxed Warnings for CAR T-Cell Immunotherapies

19.04.2024 | Targeted Oncology

Following an investigation that began in November 2023, the FDA now requires boxed warnings regarding T-cell malignancies on all BCMA- and ...

Researchers Discover Novel Cell Type that Controls the Formation and Growth of New Blood Vessels

19.04.2024 | Bionity.COM

Molecular Code Stimulates Pioneer Cells to Build Blood Vessels in the Body ...

European Union: European Parliament Backs Reforms To The EU Regulatory Framework For Medicinal Products

18.04.2024 | Mondaq Business Briefing

Members of the European Parliament (MEPs) have voted overwhelmingly in favour of the pharmaceutical reform package following a debate on 10 ...

Bioinspired and biomimetic protein-based fibers and their applications

18.04.2024 | Nature

Protein-based fibers combine unique mechanical properties with biocompatibility and biodegradability, and often outperform polymer-based ...

What Time Is Best To Bring My CDMO On Board?

17.04.2024 | BioProcess Online

By Alex Santos, CMC regulatory scientist Traditionally, biopharmaceutical companies employed an in-house approach, keeping product ...

Acoustothermal transfection for cell therapy

17.04.2024 | Science.org

AbstractTransfected stem cells and T cells are promising in personalized cell therapy and immunotherapy against various diseases. However, ...

SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids

16.04.2024 | Nature

SARS-CoV-2 provokes devastating tissue damage by cytokine release syndrome and leads to multi-organ failure. Modeling the process of immune ...

Optimising Time-to-Market for Innovative Cell Therapy Trials

16.04.2024 | European Pharmaceutical Manufacturer

Across the biopharmaceutical industry, many have expressed concern about the protracted timelines for drug development, which on average ...

Energy metabolism as therapeutic target for aged wound repair by engineered extracellular vesicle

12.04.2024 | Science.org

AbstractAging skin, vulnerable to age-related defects, is poor in wound repair. Metabolic regulation in accumulated senescent cells (SnCs) ...

Cell Counting Is Growing More Important Amid Advanced Therapy's Rise

12.04.2024 | BioProcess Online

By Pankaj Singh, Global Market Insights Cell counting is a fundamental technique used across the life sciences, from medical testing to ...

Can TILs Help to Determine Outcomes in Triple-Negative Breast Cancer?

12.04.2024 | The ASCO Post

By The ASCO Post Staff Posted: 4/3/2024 9:28:00 AM Last Updated: 4/3/2024 9:40:20 AM High levels of tumor-infiltrating lymphocytes (TILs ...

Ellen Sons Brinkmann

Kostenlose Erstberatung - jetzt Kontakt aufnehmen!

Dr. Ellen Sons-Brinkmann
Tel: +49 69 153 293 709
Mail.: ellen.sons-brinkmann@valicare.com